Virtu Financial’s BioLineRX BLRX Stock Holding History

Virtu Financial’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-533	Closed	-$11K	–	1566
2024 Q3	$11K	Buy	+533	New	+$14.6K	﹤0.01%	1189
2024 Q1	–	Sell	-759	Closed	-$48K	–	1434
2023 Q4	$48K	Buy	759 +178	+31%	+$11K	﹤0.01%	1174
2023 Q3	$42K	Buy	581 +292	+101%	+$19.6K	﹤0.01%	925
2023 Q2	$18K	Buy	+289	New	+$16K	﹤0.01%	1278
2022 Q4	–	Sell	-1,154	Closed	-$43K	–	1632
2022 Q3	$43K	Buy	1,154 +764	+196%	+$43.6K	﹤0.01%	1235
2022 Q2	$20K	Buy	+390	New	+$21.7K	﹤0.01%	1325
2021 Q3	–	Sell	-414	Closed	-$47K	–	1531
2021 Q2	$47K	Buy	+414	New	+$48.7K	﹤0.01%	1341
2019 Q2	–	Sell	-21	Closed	-$5K	–	1471
2019 Q1	$5K	Buy	+21	New	+$6.12K	﹤0.01%	1356
2018 Q2	–	Sell	-118	Closed	-$61K	–	1989
2018 Q1	$61K	Buy	+118	New	+$72.3K	﹤0.01%	1675

Other funds holding BLRX

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

VFA

Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

OGF

Orin Green Financial San Diego, California $271M AUM 20.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Virtu Financial's BLRX Position: Q4 2024 in Review

Virtu Financial sold out of BioLineRX (BLRX) in Q4 2024, closing a stake of 533 shares — an estimated $11K sold.

Virtu Financial first reported a position in BLRX in Q1 2018 and held it in 9 quarters. The position peaked at $61K in Q1 2018. 31 funds tracked by Wall St. Rank hold BLRX as of Q4 2024.

Virtu Financial reported no remaining BioLineRX position as of Q4 2024 after selling out during the quarter.
Virtu Financial sold 533 BioLineRX shares in Q4 2024, an estimated $11K.
Virtu Financial first reported a position in BioLineRX in Q1 2018 and held it in 9 quarters.
Virtu Financial's BioLineRX position peaked at $61K in Q1 2018.
31 funds tracked by Wall St. Rank held BioLineRX as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.